[1]
D. Orsini, “Brodalumab efficacy in psoriasis patients with inadequate response to IL-23 or IL-12/23 inhibitors: multicenter Italian retrospective analysis - IL PSO (Italian Landscape Psoriasis)”, Dermatol Pract Concept, vol. 15, no. 4, p. 6010, Oct. 2025, doi: 10.5826/dpc.1504a6010.